Fundz

Shenzhen Baiyin Biotechnology raised over 200 million yuan in Series A, with L'Oréal's Shanghai Meicifang joining as shareholder.

PRIVATENov 06, 2026

Amount Raised

¥200 Million

Round Type

Series A

BiotechnologyFashionBeauty

Investors

Shanghai Meicifang

Description

Shenzhen Baiyin Biotechnology Co., Ltd. completed a Series A financing round of over 200 million yuan in October. Shanghai Meicifang, L'Oréal's local investment platform in China, was added to the company's shareholder list during this period. Baiyin Biotechnology develops innovative biomaterials using synthetic biology and artificial intelligence

Quick answer

Shenzhen Baiyin Biotechnology Ltd raised ¥200 Million in a Series A round, dated September 1, 2026. Investors: Shanghai Meicifang.

How much did Shenzhen Baiyin Biotechnology Ltd raise?
Shenzhen Baiyin Biotechnology Ltd raised ¥200 Million in a Series A round on September 1, 2026.
Who invested in Shenzhen Baiyin Biotechnology Ltd?
Shanghai Meicifang is named as investors in this round.
What does Shenzhen Baiyin Biotechnology Ltd do?
L'Oréal is a global beauty company making strategic investments in the Chinese market through minority equity participation and industrial funds.

Source: Fundz verified event record.

Who else raised in Fashion and Beauty around the same time

Companies in the same sectors as Shenzhen Baiyin Biotechnology Ltd that raised within 45 days of this round, from Fundz verified event records.

  • LNGVTY raised $518K (Seed) on July 20, 2026.
  • Formial Labs raised $303K (Pre-Seed) on October 15, 2026.
  • Amaani raised $5M (Series A) on September 28, 2026.
  • Arey raised an undisclosed amount (Series A) on September 22, 2026.
  • Half Magic Beauty raised an undisclosed amount (Series A) on September 18, 2026.
  • Firi raised $3M (Seed) on September 15, 2026.

Who to call at Shenzhen Baiyin Biotechnology Ltd, and when

A new round usually means Shenzhen Baiyin Biotechnology Ltd is about to hire and buy. The teams that reach out first get the meeting.

  • An alert the day Shenzhen Baiyin Biotechnology Ltd raises, hires an executive or expands, scored against what you sell
  • The decision-makers there, with verified emails
  • Who you already know at Shenzhen Baiyin Biotechnology Ltd, from your own LinkedIn network

Works inside ChatGPT and Claude. Ask who to call at Shenzhen Baiyin Biotechnology Ltd. With Fundz connected, it knows.

Watch Fundz in
See plan options
Trusted byOracleSnowflakeCloudflareLinkedInGoogleSalesforce 4.8/5 on G2

Company Information

Company

Shenzhen Baiyin Biotechnology Ltd

About

L'Oréal is a global beauty company making strategic investments in the Chinese market through minority equity participation and industrial funds. The company is investing in emerging Chinese beauty brands, biomaterial technologies, and content-driven makeup brands to access new capabilities, channels, and technologies. L'Oréal established Cathay Beauty Future Fund jointly with Cathay Capital and the Jing'an District government to target next-generation enterprises with scientific efficacy and Chinese aesthetic characteristics.

AI made execution free. Knowing first is the whole game now.

Fundz sees it the moment Shenzhen Baiyin Biotechnology Ltd raises, hires an exec or expands, usually minutes after it happens, and tells you who to reach.

Predictive Intelligence
Strategic

ML-powered predictions for Shenzhen Baiyin Biotechnology Ltd's next move

See what Strategic adds

Funding Insights

What this usually means
Typical timeline to Series B
Series A companies typically raise their next round in 10-18 months

Shenzhen Baiyin Biotechnology Ltd raised. Fundz records a round at a median of 3.6 minutes from the SEC filing, with the decision-maker attached.

145 of these a day, filtered to the companies you pick, with the decision-maker attached.

5 screens from a live account. No signup.

Fundz is a real-time business intelligence platform powered by agentic AI that proactively delivers personalized daily signals, including funding rounds, executive changes, M&A activity, 13F institutional filings, SEC 8-K events, investor activity, and website modifications, based on each user's watchlist and ICP. A trusted data source at firms such as BlackRock, Oracle, Kleiner Perkins, LinkedIn, HubSpot, and Cloudflare, Fundz democratizes the institutional-grade intelligence that previously required a PitchBook or Bloomberg terminal. Features include Daily Briefing for AI-powered daily briefings, and unified cross-signal alerts across 281,000+ organizations. Developers and data teams can access these signals programmatically via the Fundz Funding Data API, with transparent published pricing.